Bilaketaren emaitzak - Ningjing Lin
- Erakusten 1 - 8 emaitzak -- 8
-
1
Glioblastoma Multiforme Oncogenomics and Signaling Pathways nork Okezie Obasi Kanu, Betsy D. Hughes, Chunhui Di, Ningjing Lin, Jinrong Fu, Darell D. Bigner, Hai Yan, Cory Adamson
Argitaratua 2009Artigo -
2
Sequential Ubiquitination and Phosphorylation Epigenetics Reshaping by MG132‐Loaded Fe‐MOF Disarms Treatment Resistance to Repulse Metastatic Colorectal Cancer nork Zhaoting Bu, Jianjun Yang, Yan Zhang, Tao Luo, Chao Fang, Xiayi Liang, Qiuxia Peng, Duo Wang, Ningjing Lin, Kun Zhang, Weizhong Tang
Argitaratua 2023Artigo -
3
A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type nork Ningjing Lin, Yuqin Song, Wen Zheng, Meifeng Tu, Yan Xie, Xiaopei Wang, Lingyan Ping, Zhitao Ying, Chen Zhang, Lijuan Deng, Weiping Liu, Jun Zhu
Argitaratua 2013Artigo -
4
Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma nork Zhitao Ying, Ting He, Xiaopei Wang, Wen Zheng, Ningjing Lin, Meifeng Tu, Yan Xie, Lingyan Ping, Chen Zhang, Weiping Liu, Lijuan Deng, Feifei Qi, Yanping Ding, Xin‐an Lu, Yuqin Song, Jun Zhu
Argitaratua 2019Artigo -
5
Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades nork Weiping Liu, Xinqiang Ji, Yuqin Song, Xiaopei Wang, Wen Zheng, Ningjing Lin, Meifeng Tu, Yan Xie, Lingyan Ping, Zhitao Ying, Chen Zhang, Lijuan Deng, Meng Wu, Feier Feng, Xin Leng, Yingli Sun, Tingting Du, Jun Zhu
Argitaratua 2020Artigo -
6
Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin nork Lijuan Deng, Yuqin Song, Ken H. Young, Shimin Hu, Ning Ding, Weiwei Song, Xianghong Li, Yunfei Shi, Huiying Huang, Weiping Liu, Wen Zheng, Xiaopei Wang, Yan Xie, Ningjing Lin, Meifeng Tu, Lingyan Ping, Zhitao Ying, Chen Zhang, Yingli Sun, Jun Zhu
Argitaratua 2015Artigo -
7
Efficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical Hodgkin lymphoma: A multicenter, single-arm, phase II study nork Ningjing Lin, Mingzhi Zhang, Hai Bai, Hui Liu, Jie Cui, Xiaoyan Ke, Huilai Zhang, Lihong Liu, Dongmei Yan, Yongsheng Jiang, Aimin Zang, Junyuan Qi, Li Wang, Zhuogang Liu, Bing Xu, Ying Zhang, Zhihui Zhang, Xielan Zhao, Chunhong Hu, Shenmiao Yang, Hui Zhou, Jinsheng Shi, Zonghong Shao, Ying Xiang, Jiman Zhu, Yuqin Song, Jun Zhu
Argitaratua 2021Artigo -
8
A safe and potent anti-CD19 CAR T cell therapy nork Zhitao Ying, Xue F. Huang, Xiaoyu Xiang, Yanling Liu, Xi Kang, Yuqin Song, Xiaokai Guo, Hanzhi Liu, Ning Ding, Tingting Zhang, Panpan Duan, Yufu Lin, Wen Zheng, Xiaopei Wang, Ningjing Lin, Meifeng Tu, Yan Xie, Chen Zhang, Weiping Liu, Lijuan Deng, Shun‐Yu Gao, Lingyan Ping, Xuejuan Wang, Nina Zhou, Junqing Zhang, Yulong Wang, Songfeng Lin, Mierzhati Mamuti, Xueyun Yu, Lizhu Fang, Shuai Wang, Haifeng Song, Guan Wang, Lindsey Jones, Jun Zhu, Si–Yi Chen
Argitaratua 2019Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Internal medicine
Medicine
Lymphoma
Gastroenterology
Immunology
Immune system
T cell
Adverse effect
Biology
CD19
Cancer research
Chemotherapy
Chimeric antigen receptor
Clinical endpoint
Clinical trial
Cytokine release syndrome
Genetics
Phases of clinical research
Surgery
Anaplastic large-cell lymphoma
Antigen
Asparaginase
Astrobiology
Biochemistry
Bioinformatics
Brain tumor
CD28
CHOP
Cancer
Cell biology